212 related articles for article (PubMed ID: 27819270)
1. A microfluidic device for measuring cell migration towards substrate-bound and soluble chemokine gradients.
Schwarz J; Bierbaum V; Merrin J; Frank T; Hauschild R; Bollenbach T; Tay S; Sixt M; Mehling M
Sci Rep; 2016 Nov; 6():36440. PubMed ID: 27819270
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
Haessler U; Pisano M; Wu M; Swartz MA
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Analysis of Dendritic Cell Haptotaxis.
Schwarz J; Sixt M
Methods Enzymol; 2016; 570():567-81. PubMed ID: 26921962
[TBL] [Abstract][Full Text] [Related]
4. Interstitial dendritic cell guidance by haptotactic chemokine gradients.
Weber M; Hauschild R; Schwarz J; Moussion C; de Vries I; Legler DF; Luther SA; Bollenbach T; Sixt M
Science; 2013 Jan; 339(6117):328-32. PubMed ID: 23329049
[TBL] [Abstract][Full Text] [Related]
5. Nano-scale microfluidics to study 3D chemotaxis at the single cell level.
Frick C; Dettinger P; Renkawitz J; Jauch A; Berger CT; Recher M; Schroeder T; Mehling M
PLoS One; 2018; 13(6):e0198330. PubMed ID: 29879160
[TBL] [Abstract][Full Text] [Related]
6. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells.
Schumann K; Lämmermann T; Bruckner M; Legler DF; Polleux J; Spatz JP; Schuler G; Förster R; Lutz MB; Sorokin L; Sixt M
Immunity; 2010 May; 32(5):703-13. PubMed ID: 20471289
[TBL] [Abstract][Full Text] [Related]
7. Dendritic Cells Interpret Haptotactic Chemokine Gradients in a Manner Governed by Signal-to-Noise Ratio and Dependent on GRK6.
Schwarz J; Bierbaum V; Vaahtomeri K; Hauschild R; Brown M; de Vries I; Leithner A; Reversat A; Merrin J; Tarrant T; Bollenbach T; Sixt M
Curr Biol; 2017 May; 27(9):1314-1325. PubMed ID: 28457871
[TBL] [Abstract][Full Text] [Related]
8. Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.
Hansen M; Met Ö; Larsen NB; Rosenkilde MM; Andersen MH; Svane IM; Hjortø GM
Cytotherapy; 2016 Sep; 18(9):1187-96. PubMed ID: 27424146
[TBL] [Abstract][Full Text] [Related]
9. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.
Nandagopal S; Wu D; Lin F
PLoS One; 2011 Mar; 6(3):e18183. PubMed ID: 21464944
[TBL] [Abstract][Full Text] [Related]
11. Immobilisation of CXCL8 gradients in microfluidic devices for migration experiments.
Kilb MF; Engemann VI; Siddique A; Stark RW; Schmitz K
Colloids Surf B Biointerfaces; 2021 Feb; 198():111498. PubMed ID: 33302150
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CCR7 mediated T cell transfectant migration using a microfluidic gradient generator.
Wu X; Wu J; Li H; Legler DF; Marshall AJ; Lin F
J Immunol Methods; 2015 Apr; 419():9-17. PubMed ID: 25733353
[TBL] [Abstract][Full Text] [Related]
13. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes.
Kuscher K; Danelon G; Paoletti S; Stefano L; Schiraldi M; Petkovic V; Locati M; Gerber BO; Uguccioni M
Eur J Immunol; 2009 Apr; 39(4):1118-28. PubMed ID: 19291700
[TBL] [Abstract][Full Text] [Related]
14. CCR7 signaling inhibits T cell proliferation.
Ziegler E; Oberbarnscheidt M; Bulfone-Paus S; Förster R; Kunzendorf U; Krautwald S
J Immunol; 2007 Nov; 179(10):6485-93. PubMed ID: 17982037
[TBL] [Abstract][Full Text] [Related]
15. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.
Jørgensen AS; Adogamhe PE; Laufer JM; Legler DF; Veldkamp CT; Rosenkilde MM; Hjortø GM
J Leukoc Biol; 2018 Aug; 104(2):401-411. PubMed ID: 29768676
[TBL] [Abstract][Full Text] [Related]
16. Migrating Myeloid Cells Sense Temporal Dynamics of Chemoattractant Concentrations.
Petrie Aronin CE; Zhao YM; Yoon JS; Morgan NY; Prüstel T; Germain RN; Meier-Schellersheim M
Immunity; 2017 Nov; 47(5):862-874.e3. PubMed ID: 29166587
[TBL] [Abstract][Full Text] [Related]
17. A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4.
Jafarnejad M; Zawieja DC; Brook BS; Nibbs RJB; Moore JE
J Immunol; 2017 Oct; 199(7):2291-2304. PubMed ID: 28807994
[TBL] [Abstract][Full Text] [Related]
18. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
19. Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration.
de la Rosa G; Longo N; Rodríguez-Fernández JL; Puig-Kroger A; Pineda A; Corbí AL; Sánchez-Mateos P
J Leukoc Biol; 2003 May; 73(5):639-49. PubMed ID: 12714579
[TBL] [Abstract][Full Text] [Related]
20. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2.
Scandella E; Men Y; Legler DF; Gillessen S; Prikler L; Ludewig B; Groettrup M
Blood; 2004 Mar; 103(5):1595-601. PubMed ID: 14592837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
